JUXTAPID Trademark

Trademark Overview

On Friday, December 14, 2012, a trademark application was filed for JUXTAPID with the United States Patent and Trademark Office. The USPTO has given the JUXTAPID trademark a serial number of 85980934. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, May 2, 2020. This trademark is owned by Aegerion Pharmaceuticals, Inc.. The JUXTAPID trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA
juxtapid

General Information

Serial Number85980934
Word MarkJUXTAPID
Filing DateFriday, December 14, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, May 2, 2020
Registration Number4508190
Registration DateTuesday, April 1, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2013

Trademark Statements

Goods and ServicesPHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 2, 2013
Primary Code005
First Use Anywhere DateMonday, January 28, 2013
First Use In Commerce DateMonday, January 28, 2013

Trademark Owner History

Party NameAMRYT PHARMACEUTICALS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDUBLIN 4
IE
Party NameAegerion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, March 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 18, 2012NEW APPLICATION ENTERED
Wednesday, January 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 30, 2013ASSIGNED TO EXAMINER
Wednesday, April 3, 2013ASSIGNED TO LIE
Saturday, April 6, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, December 17, 2013TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 17, 2013DIVISIONAL REQUEST RECEIVED
Thursday, January 9, 2014SOU TEAS EXTENSION RECEIVED
Sunday, February 9, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 11, 2014DIVISIONAL PROCESSING COMPLETE
Monday, February 24, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, January 9, 2014USE AMENDMENT FILED
Tuesday, February 11, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, February 24, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 2, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 25, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 1, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, April 18, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, April 1, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 10, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, May 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 1, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, May 2, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 23, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 5, 2024TEAS SECTION 8 & 9 RECEIVED

Related Keywords

juxtapid particular hyperlipidemia disorders cardiovascular treatment pharmaceuticals